Current Disease Management of Primary Urethral Carcinoma

Visser, 2012, Incidence and survival of rare urogenital cancers in Europe, Eur J Cancer, 48, 456, 10.1016/j.ejca.2011.10.031 Gatta, 2011, Rare cancers are not so rare: the rare cancer burden in Europe, Eur J Cancer, 47, 2493, 10.1016/j.ejca.2011.08.008 Swartz, 2006, Incidence of primary urethral carcinoma in the United States, Urology, 68, 1164, 10.1016/j.urology.2006.08.1057 Shariat, 2009, Bladder cancer in the elderly, Urol Oncol, 27, 653, 10.1016/j.urolonc.2009.07.020 Van de Voorde, 1994, Urethral squamous cell carcinoma associated with urethral stricture and urethroplasty, Eur J Surg Oncol, 20, 478 Thomas, 2008, Urethral diverticula in 90 female patients: a study with emphasis on neoplastic alterations, J Urol, 180, 2463, 10.1016/j.juro.2008.08.040 Cupp, 1996, Detection of human papillomavirus DNA in primary squamous cell carcinoma of the male urethra, Urology, 48, 551, 10.1016/S0090-4295(96)00246-4 Guo, 2018, Lichen sclerosus accompanied by urethral squamous cell carcinoma: a retrospective study from a urethral referral center, Am J Mens Health, 12, 1692, 10.1177/1557988318782095 Zhang, 2018, Carcinoma of the urethra, Hum Pathol, 72, 35, 10.1016/j.humpath.2017.08.006 Wells, 2000 Cahn, 2017, Contemporary practice patterns and survival outcomes for locally advanced urethral malignancies: a National Cancer Database analysis, Urol Oncol, 35, e15 Champ, 2012, Prognostic factors and outcomes after definitive treatment of female urethral cancer: a population-based analysis, Urology, 80, 374, 10.1016/j.urology.2012.02.058 Dayyani, 2013, Retrospective analysis of survival outcomes and the role of cisplatin-based chemotherapy in patients with urethral carcinomas referred to medical oncologists, Urol Oncol, 31, 1171, 10.1016/j.urolonc.2012.01.011 Gakis, 2015, Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma, Ann Oncol, 26, 1754, 10.1093/annonc/mdv230 Gakis, 2018, The prognostic effect of salvage surgery and radiotherapy in patients with recurrent primary urethral carcinoma, Urol Oncol, 36 Peyton, 2018, Survival outcomes associated with female primary urethral carcinoma: review of a single institutional experience, Clin Genitourin Cancer, 16, 10.1016/j.clgc.2018.05.012 Rabbani, 2011, Prognostic factors in male urethral cancer, Cancer, 117, 2426, 10.1002/cncr.25787 Son, 2018, Optimizing the role of surgery and radiation therapy in urethral cancer based on histology and disease extent, Int J Radiat Oncol Biol Phys, 102, 304, 10.1016/j.ijrobp.2018.06.007 Wei, 2017, Sex-related differences in clinicopathological features and survival of patients with primary urethral carcinoma: a population-based study, OncoTargets Ther, 10, 3381, 10.2147/OTT.S139252 Moher, 2015, Preferred Reporting Items for Systematic Review and Meta-analysis protocols (PRISMA-P) 2015 statement, Syst Rev, 4, 1, 10.1186/2046-4053-4-1 Derksen, 2013, Primary urethral carcinoma in females: an epidemiologic study on demographical factors, histological types, tumour stage and survival, World J Urol, 31, 147, 10.1007/s00345-012-0882-5 Gakis, 2013, EAU guidelines on primary urethral carcinoma, Eur Urol, 64, 823, 10.1016/j.eururo.2013.03.044 Spiess, 2017, Bladder cancer, version 5.2017, NCCN clinical practice guidelines in oncology, J Natl Compr Canc Netw, 15, 1240, 10.6004/jnccn.2017.0156 Comperat, 2016, Immunochemical and molecular assessment of urothelial neoplasms and aspects of the 2016 World Health Organization classification, Histopathology, 69, 717, 10.1111/his.13025 2017, 208 Gheiler, 1998, Management of primary urethral cancer, Urology, 52, 487, 10.1016/S0090-4295(98)00199-X Touijer, 2004, Role of voided urine cytology in diagnosing primary urethral carcinoma, Urology, 63, 33, 10.1016/j.urology.2003.08.007 Donat, 2001, The efficacy of transurethral biopsy for predicting the long-term clinical impact of prostatic invasive bladder cancer, J Urol, 165, 1580, 10.1016/S0022-5347(05)66352-5 Kakizoe, 1998, Transitional cell carcinoma of the urethra in men and women associated with bladder cancer, Jpn J Clin Oncol, 28, 357, 10.1093/jjco/28.6.357 Gakis, 2016, Oncological outcomes of patients with concomitant bladder and urethral carcinoma, Urol Int, 97, 134, 10.1159/000448335 Gakis, 2016, Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinoma, World J Urol, 34, 97, 10.1007/s00345-015-1583-7 Itani, 2016, MRI of female urethra and periurethral pathologies, Int Urogynecol J, 27, 195, 10.1007/s00192-015-2790-x Smith, 2007, Penile-preserving surgery for male distal urethral carcinoma, BJU Int, 100, 82, 10.1111/j.1464-410X.2007.06901.x Torbrand, 2017, Diagnosing distal urethral carcinomas in men might be only the tip of the iceberg, Clin Genitourin Cancer, 15, e1131, 10.1016/j.clgc.2017.07.006 Karnes, 2010, Surgery for urethral cancer, Urol Clin North Am, 37, 445, 10.1016/j.ucl.2010.04.011 Kang, 2015, Survival outcomes and predictive factors for female urethral cancer: Long-term experience with Korean patients, J Korean Med Sci, 30, 1143, 10.3346/jkms.2015.30.8.1143 Garden, 1993, Primary carcinoma of the female urethra. Results of radiation therapy, Cancer, 71, 3102, 10.1002/1097-0142(19930515)71:10<3102::AID-CNCR2820711034>3.0.CO;2-2 Dimarco, 2004, Surgical treatment for local control of female urethral carcinoma, Urol Oncol, 22, 404, 10.1016/S1078-1439(03)00174-1 Ahmed, 2010, Urethral diverticular carcinoma: an overview of current trends in diagnosis and management, Int Urol Nephrol, 42, 331, 10.1007/s11255-009-9618-x Zinman, 2016, Management of proximal primary urethral cancer: should multidisciplinary therapy be the gold standard?, Urol Clin North Am, 43, 505, 10.1016/j.ucl.2016.06.011 Dayyani, 2014, Management of advanced primary urethral carcinomas, BJU Int, 114, 25, 10.1111/bju.12630 Dinney, 1994, Therapy and prognosis for male anterior urethral carcinoma: an update, Urology, 43, 506, 10.1016/0090-4295(94)90242-9 Dalbagni, 1999, Male urethral carcinoma: analysis of treatment outcome, Urology, 53, 1126, 10.1016/S0090-4295(98)00659-1 Lughezzani, 2010, A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma, Urology, 75, 118, 10.1016/j.urology.2009.07.1296 Ray, 1977, Experience with primary carcinoma of the male urethra, J Urol, 117, 591, 10.1016/S0022-5347(17)58546-8 Babjuk, 2017, EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016, Eur Urol, 71, 447, 10.1016/j.eururo.2016.05.041 Thyavihally, 2006, Clinical outcome of 36 male patients with primary urethral carcinoma: a single center experience, Int J Urol, 13, 716, 10.1111/j.1442-2042.2006.01392.x Cohen, 2008, Coordinated chemoradiation therapy with genital preservation for the treatment of primary invasive carcinoma of the male urethra, J Urol, 179, 536, 10.1016/j.juro.2007.09.068 Ploussard, 2014, Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review, Eur Urol, 66, 120, 10.1016/j.eururo.2014.02.038 DeConti, 2012, Chemotherapy of squamous cell carcinoma of the skin, Semin Oncol, 39, 145, 10.1053/j.seminoncol.2012.01.002 Zargar, 2015, Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer, Eur Urol, 67, 241, 10.1016/j.eururo.2014.09.007 Dalbagni, 1998, Female urethral carcinoma: an analysis of treatment outcome and a plea for a standardized management strategy, Br J Urol, 82, 835, 10.1046/j.1464-410X.1998.00878.x Matzkin, 1991, Transitional cell carcinoma of the prostate, J Urol, 146, 1207, 10.1016/S0022-5347(17)38047-3 Njinou Ngninkeu, 2003, Transitional cell carcinoma involving the prostate: a clinicopathological retrospective study of 76 cases, J Urol, 169, 149, 10.1016/S0022-5347(05)64056-6 Palou Redorta, 2006, Intravesical instillations with bacillus Calmette-Guerin for the treatment of carcinoma in situ involving prostatic ducts, Eur Urol, 49, 834, 10.1016/j.eururo.2005.12.019 Palou, 2007, Urothelial carcinoma of the prostate, Urology, 69, 50, 10.1016/j.urology.2006.05.059 Schellhammer, 1995, Intravesical bacillus Calmette-Guerin for treatment of superficial transitional cell carcinoma of the prostatic urethra in association with carcinoma of the bladder, J Urol, 153, 53, 10.1097/00005392-199501000-00020 Gofrit, 2009, Prostatic urothelial carcinoma: is transurethral prostatectomy necessary before bacillus Calmette-Guerin immunotherapy?, BJU Int, 103, 905, 10.1111/j.1464-410X.2008.08210.x Ichihara, 2014, Clinical outcomes of urothelial carcinoma of the prostate detected in radical cystectomy specimens, Int J Clin Oncol, 19, 152, 10.1007/s10147-012-0508-3 Knoedler, 2014, Urothelial carcinoma involving the prostate: the association of revised tumour stage and coexistent bladder cancer with survival after radical cystectomy, BJU Int, 114, 832, 10.1111/bju.12486 Sakamoto, 1993, An adequate sampling of the prostate to identify prostatic involvement by urothelial carcinoma in bladder cancer patients, J Urol, 149, 318, 10.1016/S0022-5347(17)36068-8 Solsona, 1995, The prostate involvement as prognostic factor in patients with superficial bladder tumors, J Urol, 154, 1710, 10.1016/S0022-5347(01)66762-4